Distributed Development Company News Today

The New York based biotech company announces launch of Amplifier Therapeutics to develop the clinical stage pan-AMPK activator, ATX-304 NEW YORK, March 14, 2023 /PRNewswire/ -- Cambrian

/PRNewswire/ -- Cambrian BioPharma, a multi-asset longevity biotech, today unveils its latest pipeline company, Isterian Biotech. This preclinical start-up is...

/PRNewswire/ -- Cambrian BioPharma, a multi-asset longevity biotech, today announced that its CEO, James Peyer, has been selected as "BioTech Company CEO of...

- Fundraising led by Cambrian BioPharma and Solve FSHD -- Company expands pipeline with new program, VTA-120, for the treatment of facioscapulohumeral muscular dystrophy (FSHD) -BALTIMORE--(BUSINESS WIRE)--Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therap...

/PRNewswire/ -- Cambrian BioPharma, a multi-asset longevity biotech, today announces its Scientific Advisory Board (SAB) and appointment of C. David Nicholson,...

/PRNewswire/ -- Oviva Therapeutics, Inc. (Oviva), the womens health biotech company and a Cambrian Biopharma *PipeCo, today announced an in-licensing...

NEW YORK, Feb. 16, 2022 /PRNewswire/ -- Cambrian Biopharma, a multi-asset longevity biotech, today announced a licensing agreement with Novartis t...

/PRNewswire/ -- Cambrian Biopharma, a multi-asset longevity biotech, today announced a licensing agreement with Novartis to advance novel, selective compounds...

/PRNewswire/ -- Cambrian Biopharma, a multi-asset longevity biotech, today announced a licensing agreement with Novartis to advance novel, selective compounds...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!